Investing.com - (NYSE:Abbott Laboratories) reported first-quarter earnings that beat estimates.
The U.S.pharmaceutical posted adjusted diluted Q1 EPS of $0.48 vs. estimate of $0.43 and $0.41 a year earlier.
Revenues rose 29.7% on a reported basis from a year earlier to $6.3 bn.
Abbott shares were up 2.92% at $44.70 in pre-market trade.